Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2024Cancer Research

Abstract 5959: Targeting TRIM11 is a potential therapeutic strategy for malignant gliomas

View Full Paper
Ask AI
Bookmark
Share

Authors

KDKaijun DiBDBhaskar C. DasDADaniela Alexandru

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Di et al. (2024) studied this question.

synapsesocial.com/papers/68e72f4bb6db6435876a881fhttps://doi.org/10.1158/1538-7445.am2024-5959
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TRIM21 drives glioblastoma malignancy via ubiquitination-mediated PDGFRA degradation.2026 · 1 citations
  2. 2TRIM47-mediated Ubiquitination of p53 Controls Proliferative Progression and Stress Adaptation in Glioblastoma2026
  3. 37559 TRIM21 Regulates Activation of ERK1/2 to Promote Growth and Drug Resistance in Pituitary Neuroendocrine Tumors2024
  4. 4TRIM11 expression in non-small cell lung cancer is associated with poor prognosis.2024 · 4 citations
  5. 5TRIM22 promotes glioblastoma development by ubiquitinating Bcl-22025 · 1 citations